Skip to main content
OpenTrials
Completed

NCT Number: NCT04682938

The Prevalence and Characteristics of Adrenal Incidentaloma

To investige the prevalence, characteristics and prognosis of adrenal incidentalomas in Chinese adults.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–78 year

Sex eligibility

All sexes

Study type

Observational

Primary location

the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Chongqing, Chongqing Municipality, 400016, China

About this study

With the development of imaging detection technology and its wide application in clinic, the detection rate of adrenal incidentaloma (AI) has been greatly improved. Most AI are benign and do not have the function of autonomic hormone secretion, but about 20% of them have function and can secrete adrenal hormone autonomously. Studies based on biopsy reports show that the prevalence of AI is about 2%, and the prevalence of AI detected by CT scan is 1% - 4.5%. However, most of these studies are retrospective, and there may be selection bias and other confounding factors. There is no large sample prospective study on the prevalence of AI in the general population. The purpose of this study is to prospectively include patients with adrenal incidentaloma in community physical examination population, and evaluate their function and prognosis. The research results will provide new evidence for standardized diagnosis and treatment of adrenal incidentaloma in the future.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

·On weekdays, the first 100 individuals, aged 18 to 78 years, taking health checkup in the Community Health Examination Center were invited to take part in the study.

Exclusion criteria

  • with known adrenal diseases;
  • with continuous steroids or drug treatment that might influence cortisol secretion ordexamethasone metabolism and could not be stopped
  • refuse to participate in the study.

Treatment and study plan

Primary outcomes

  1. Prevalence and Characteristics of Adrenal Incidentaloma

    Time frame: 1 years

    To investigate the prevalence and characteristics of Adrenal Incidentaloma in general population in China

Secondary outcomes

  1. Steroid hormones in the function of Adrenal Incidentaloma

    Time frame: 1 years

    prospectively evaluate potential predictive role of combined detection of multiple steroid hormones in the function of Adrenal Incidentaloma

Sponsors and collaborators

Lead sponsor

Chongqing Medical University

Other

Registry information

Official study title

The Prevalence and Characteristics of Adrenal Incidentaloma: A Prospective Study

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Dec 24, 2020
Registry last updated
Aug 10, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.